drugset / Trial / NCT03524963

Comparative Pharmacokinetic Study Between Two Extended-Release Cilostazol Formulations in Korea

NCT03524963

Phase 1 Completed 30 enrolled Bundang CHA Hospital
RandomizedCrossoverOpen-labelTreatment

Summary

This is a randomized, open-label, multiple-dose, two-sequence, two-period crossover study to to compare the safety/tolerability and pharmacokinetics between Pletaal SR Cap. and Cilostan CR Tab. in healthy volunteers

Timeline

Start
2017-08-07
Primary completion
2018-05-30
Completion
2018-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Cilostazol Small molecule 200 mg